Welcome to the new Process Development Forum
August 7, 2013 - Cytiva and BioPharm International
August 15, 2013
Welcome to the new Bioprocess Development Forum (PDF) website.
We launched www.ProcessDevelopmentForum.com two years ago a
…
QbD and PAT in Upstream and Downstream Processing
August 5, 2013 - Susan Haigney , Managing Editor, BioPharm International Magazine
Quality by Design: A CMO's Perspective on Gaining Knowledge Faste
July 22, 2013 - By: Clinton Weber, Ashok Kumar, Roland Ashton, Lisa Joslin, James Schmid, Michael Larson, BioPharm I
From a CMO perspective, the traditional strategy behind process development has largely been to quickly identify target operational values that hit a primary quality
…
Addressing the Challenges in Downstream Processing Today and Tomo
July 5, 2013 - BioPharm International
Newer classes of biotherapies will require innovations in processing technology.
By Glen R. Bolton, Bernard N. Violand, Richard S. Wright, Shujun
…
Flexibility in Biopharmaceutical Manufacturing
June 14, 2013 - BioPharm International Magazine
Maintaining flexibility in biopharmaceutical manufacturing can deliver positive results.
By: Simon Chalk
Overview of a scale-up of a cell-based influenza virus production
June 3, 2013 - Cytiva
The aim of this white paper is to demonstr
Milestones and Moderate Progress in 2012 Drug Approvals
May 28, 2013 - Gary Walsh, PhD, BioPharm International
First gene therapy and plant-based expression vector products approved in 2012.
Advancing QbD in the EU
May 20, 2013 - Sean Milmo, BioPharm International
EU authorities are stepping up their efforts to incorporate QbD principles.
The European Commission (EC) an
…
The Lifecycle Change of Process Validation and Analytical Testing
April 8, 2013 - BioPharm International
The Future of Biopharma
March 18, 2013 - BioPharm Internationa
What the industry's future holds and what needs to be done to get there.
